首页> 外文期刊>Pathology Research and Practice >c-KIT expression in columnar cell lesions of the breast accompanied by benign and malignant breast diseases.
【24h】

c-KIT expression in columnar cell lesions of the breast accompanied by benign and malignant breast diseases.

机译:c-KIT在伴有良性和恶性乳腺疾病的乳腺柱状细胞病变中的表达。

获取原文
获取原文并翻译 | 示例
           

摘要

Columnar cell lesions (CCLs) of the breast are reported with increasing frequency. However, the significance of these lesions and the treatment approach to these lesions are still unknown. The aim of the present study was to evaluate c-KIT expression in CCLs accompanying benign and malignant breast diseases. A total of 65 patients (18 benign breast diseases, 8 ductal carcinomas in situ (DCI), and 39 invasive carcinomas) were included in the study. c-KIT was strongly expressed in normal breast epithelium (staining intensity; SI: 3 +/- 0.0), whereas a heterogeneous and cytoplasmic staining pattern was observed in CCLs accompanying both benign and malignant diseases. c-KIT expression was decreased, with increasing atypia in CCLs (SI in CCLs with/without atypia; 1.45 +/- 0.52o case, 1.25 +/- 0.50/1.38 +/- 0.52, 0.77 +/- 0.73/1.21 +/- 0.42 accompanying benign breast disease, DCI and invasive carcinoma, respectively). c-KIT expression was detected in 10.4% of invasive carcinomas. No significant associationbetween c-KIT expression and the histologic grade and nodal status of tumor was noted. As there is a reduction in c-KIT expression with malignant transformation of breast epithelium, c-KIT is believed to play a role in breast carcinogenesis. Furthermore, similar c-KIT expression patterns in CCLs accompanying malignant breast diseases suggest that at least some CCLs could reflect a premalignant status of breast carcinoma. However, the significance of c-KIT expression in CCLs and its relationship to breast carcinogenesis should be evaluated in follow up studies investigating larger series.
机译:据报道,乳房的柱状细胞病变(CCLs)的频率越来越高。然而,这些病灶的重要性和对这些病灶的治疗方法仍然未知。本研究的目的是评估伴随良性和恶性乳腺疾病的CCL中c-KIT表达。该研究共纳入65例患者(18例乳腺良性疾病,8例原位导管癌(DCI)和39例浸润性癌)。 c-KIT在正常乳腺上皮中强烈表达(染色强度; SI:3 +/- 0.0),而在伴随良性和恶性疾病的CCL中观察到异质和细胞质染色模式。 c-KIT表达降低,伴有CCL中的非典型性增加(CCL中具有/不具有非典型性的SI中的SI; 1.45 +/- 0.52 /无病例,1.25 +/- 0.50 / 1.38 +/- 0.52,0.77 +/- 0.73 / 1.21 + /-0.42,分别伴有良性乳腺疾病,DCI和浸润性癌。在10.4%的浸润性癌中检测到c-KIT表达。 c-KIT表达与肿瘤的组织学分级和淋巴结状态之间无显着关联。由于乳腺上皮的恶性转化导致c-KIT表达降低,因此c-KIT被认为在乳癌的发生中起作用。此外,伴随恶性乳房疾病的CCL中类似的c-KIT表达模式表明,至少某些CCL可以反映乳腺癌的癌前状态。但是,c-KIT表达在CCLs中的重要性及其与乳癌发生的关系应在研究较大系列的随访研究中进行评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号